Beijing Konruns Pharmaceutical Co., Ltd. Class ASSE: 603590

Announcement on presentation of KC1036 for the treatment of advanced thymic tumors in the form of a poster at the 2026 ASCO Annual Meeting

· Issued by Beijing Konruns Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on presentation of KC1036 for the treatment of advanced thymic tumors in the form of a poster at the 2026 ASCO Annual Meeting

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis